跳至主要内容
临床试验/NCT04096898
NCT04096898Unknown不适用

Clinical Trial to Determine Whether Senofilcon A Lenses Provide Relief of Symptoms and Signs in Patients With Moderate to Severe Dry Eye Disease

University of Illinois at Chicago1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2018年4月23日最近更新:
适应症

试验速览

阶段
不适用
入组人数
32
试验地点
1
主要终点
Ocular Surface Disease Index (OSDI)

研究概览

简要总结

A clinical trial using Senofilcon A daily lenses in the treatment of moderate to severe dry eye. This a comparison between signs and symptoms prior to and during treatment.

详细描述

32 patients with moderate to severe dry eye will be enrolled in this short-term proof of concept study to determine the efficacy in using soft lenses made of Senofilcon A in reducing signs and symptoms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Confirmed diagnosis of moderate to severe dry eye associated with either Graft-versus-host disease (GVHD), Sjogren syndrome, idiopathic dry eyes, or minimal limbal cell deficiency
  • •A baseline Schirmer tear test (1) of less than 5 mm at 5 minutes without anesthesia
  • •Have a visual analog score for comfort of 50 or less (scale of 1-100, with 100 meaning perfect ocular comfort and 1 meaning severe ocular pain)
  • •Ability or the resources to insert and remove the study lenses
  • •An OSDI score greater than 42
  • •A willingness to sign an informed consent

排除标准

  • •No dry eyes or mild dry eyes
  • •A baseline Schirmer tear test (1) of greater than 5 mm of wetting at 5 minutes
  • •Dry eye comfort score of greater than 50 on a visual analog scale
  • •Unable to insert or remove the study lenses (or have a family member do so)
  • •Have an OSDI score less than 42
  • •Has been diagnosed with neurotrophic keratopathy in either eye
  • •Unwilling to enroll in the study, and unwilling to provide signed informed consent to participate in the study

结局指标

主要结局

Ocular Surface Disease Index (OSDI)

时间窗: 2 weeks

Patient questionaire

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Timothy T. McMahon, OD

Dr. Timothy T. McMahon

University of Illinois at Chicago

研究点 (1)

Loading locations...

相似试验

Senofilcon A Lenses in Moderate to Severe Dry Eye... | 临床试验